Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trial.

Creators: Hartman L; El Alili M; Cutolo M; Opris D; Da Silva J; Szekanecz Z; Buttgereit F; Masaryk P; Bos R; Kok MR; Paolino S; Coupé V; Lems WF; Boers M; GLORIA consortium

Others:: Hartman, L; El Alili, M; Cutolo, M; Opris, D; Da Silva, J; Szekanecz, Z; Buttgereit, F; Masaryk, P; Bos, R; Kok, Mr; Paolino, S; Coupé, V; Lems, Wf; Boers, M; Gloria, Consortium

Additional details